Immunic, Inc. Common Stock (NASDAQ: IMUX) last traded at $16.50, up 2.48% on the session. The quote above updates while this page is open; the figures below are drawn from Immunic, Inc. Common Stock’s own filings and are restated only when a new one is published.
Immunic, Inc. Common Stock trades on NASDAQ under the ticker IMUX. Its market capitalisation is $225.13 million.
Valuation measures for Immunic, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $225.13M |
|---|---|
| Enterprise value | $101.62M |
| Price / book | 1.76 |
| Beta | 1.56 |
Trailing-twelve-month figures tagged in Immunic, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$111.57M |
|---|---|
| Return on equity | -87.45% |
| Cash | $155.10M |
Range and volume for IMUX over the past 52 weeks.
| 52-week high | $17.43 |
|---|---|
| 52-week low | $5.06 |
| Volume | 147.7K |
| Average volume | 195.8K |
| Previous close | $16.10 |
Dividend history for Immunic, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.